semaglutide being taken off the market Why weight-loss drug Wegovy is losing share in U.S Weight loss patients fret over

While semaglutide does not have direct CNS stimulant effects, some patients report fatigue or mood alterations

It is not a medicine

By potentially moderating this immune response, semaglutide could help reduce these symptoms and slow down the process that leads to skin irritation

It is being studied in clinical trials for obesity, overweight with weight-related conditions, type 2 diabetes, knee osteoarthritis pain, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease

We will help you create a plan tailored to your skin, your goals, and your weight-loss journey.

If your current insurance plan doesnt cover Ozempic or has a high copay for this medication, look for a new health plan that covers Ozempic with a lower copay